161 related articles for article (PubMed ID: 35830866)
1. A Multi-Analyte LC-MS/MS Method for Determination and Quantification of Six Nitrosamine Impurities in Sartans like Azilsartan, Valsartan, Telmisartan, Olmesartan, Losartan and Irbesartan.
Gopireddy RR; Maruthapillai A; Mahapatra S
J Chromatogr Sci; 2024 Feb; 62(2):147-167. PubMed ID: 35830866
[TBL] [Abstract][Full Text] [Related]
2. Investigation of Carcinogenic Impurities of N-Nitrosamines in Sartan Pharmaceutical Products Marketed in Brazil: Development and Validation of Method Based on High-Performance Liquid Chromatography-Tandem Mass Spectrometry.
Monteiro MA; de Lima PC; Novotny TS; Santana DS; Lima MED; Dantas ASCL; Ferreira LODS; de Souza MN; Maranho RLDN; Ochs SM
J Pharm Sci; 2023 May; 112(5):1305-1314. PubMed ID: 36657719
[TBL] [Abstract][Full Text] [Related]
3. Rapid Quantitation of Four Nitrosamine Impurities in Angiotensin Receptor Blocker Drug Substances.
Zhang J; Selaya SD; Shakleya D; Mohammad A; Faustino PJ
J Pharm Sci; 2023 May; 112(5):1246-1254. PubMed ID: 36509171
[TBL] [Abstract][Full Text] [Related]
4. Development of a sensitive LC-APCI-MS/MS method for simultaneous determination of eleven nitrosamines in valsartan and irbesartan with a simple extraction approach.
Mavis ME; Goksu Gursu G; Ular Cagatay N
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Feb; 1216():123593. PubMed ID: 36669257
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of an analytical method for trace-level quantification of genotoxic nitrosamine impurities in losartan and hydrochlorothiazide fixed-dose combination tablets using ultra performance liquid chromatography triple quadrupole mass spectrometry.
Patel R; Purohit S; Solanki R; Khunt D; Patel C; Patel R; Parikh S
Rapid Commun Mass Spectrom; 2023 Apr; 37(8):e9488. PubMed ID: 36740827
[TBL] [Abstract][Full Text] [Related]
6. An Analytical Method for Determining N-Nitrosodimethylamine and N-Nitrosodiethylamine Contamination in Irbesartan, Olmesartan and Metformin by UPLC-APCI-MS/MS in Tablet Dosage Form.
Deeb AA; Hailat M; Aldoqum HM; Abuothman M; Abuyaman O; Abu Dayyih W
J Chromatogr Sci; 2024 Apr; 62(4):372-379. PubMed ID: 37622601
[TBL] [Abstract][Full Text] [Related]
7. Nitrosamine Impurities in Pharmaceuticals: An Empirical Review of their Detection, Mechanisms, and Regulatory Approaches.
Bhirud D; Agrawal G; Shah H; Patel A; Palkar MB; Bhattacharya S; Prajapati BG
Curr Top Med Chem; 2024; 24(6):503-522. PubMed ID: 38321910
[TBL] [Abstract][Full Text] [Related]
8. Determination of Genotoxic Impurity
Xie B; Guo D; Mai B; Fan J
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364326
[No Abstract] [Full Text] [Related]
9. A GC-MS/MS Method for Trace Level Quantification of Six Nitrosamine Impurities (NDMA, NDEA, NEIPA, NDIPA, NDPA, and NDBA) in Commercially Used Organic Solvents: Dichloromethane, Ethyl Acetate, Toluene, and O-xylene.
Kosuri ER; Bhanti M; Jaywant MA; Han M; Wang X; Obeng M
J Pharm Sci; 2023 May; 112(5):1225-1230. PubMed ID: 36462706
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous and trace level quantification of two potential genotoxic impurities in valsartan drug substance using UPLC-MS/MS.
Li S; Dong L; Tang K; Lan Z; Liu R; Wang Y; Wang R; Lin H
J Pharm Biomed Anal; 2022 Apr; 212():114630. PubMed ID: 35158183
[TBL] [Abstract][Full Text] [Related]
11. Selective determination of sartan drugs in environmental water samples by mixed-mode solid-phase extraction and liquid chromatography tandem mass spectrometry.
Castro G; Rodríguez I; Ramil M; Cela R
Chemosphere; 2019 Jun; 224():562-571. PubMed ID: 30836251
[TBL] [Abstract][Full Text] [Related]
12. LC-MS/MS Investigation of nitrosamine impurities in certain Sartan group medicinal products available in Istanbul, Türkiye.
Öncü T; Yüksel B; Binay E; Şen N
Ann Pharm Fr; 2024 Jan; 82(1):72-83. PubMed ID: 37567559
[TBL] [Abstract][Full Text] [Related]
13. Thymol-Based Hydrophobic Deep Eutectic Solvents as a Green Approach for Screening Polar Nitrosamines in Sartans Pharmaceutical Products by Ultrasound-Assisted Dispersive Liquid-Liquid Microextraction Combined with HPLC-DAD.
Novotny TS; Monteiro MA; de Lima PC; Ochs SM; Maranho RLDN; Vaz FAS; Marques FFC
J Pharm Sci; 2023 May; 112(5):1231-1245. PubMed ID: 36481416
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of four Nitrosamine Impurities Determination Method in Medicines of Valsartan, Losartan, and Irbesartan with HPLC-MS/MS (APCI).
Khorolskiy M; Ramenskaya G; Vlasov A; Perederyaev O; Maslennikova N
Iran J Pharm Res; 2021; 20(3):541-552. PubMed ID: 34904007
[TBL] [Abstract][Full Text] [Related]
15. Method for trace determination of N-nitrosamines impurities in metronidazole benzoate using high-performance liquid chromatography coupled with atmospheric-pressure chemical ionization tandem mass spectrometry.
Yin M; Hu Y; Fan H; Wang Q; Wang M; Wang W; Shi C
J Sep Sci; 2023 Mar; 46(5):e2200225. PubMed ID: 36562102
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of 13 nitrosamine impurities in biological medicines using salting-out liquid-liquid extraction coupled with liquid chromatography tandem mass spectrometry.
Luo F; Liu Y; Xie Y; Hou W; Zhang L; Zhang Z
J Pharm Biomed Anal; 2022 Sep; 218():114867. PubMed ID: 35679708
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous Estimation of Six Nitrosamine Impurities in Valsartan Using Liquid Chromatographic Method.
Bodiwala KB; Panchal BG; Savale SS; Dave JB; Sureja DK; Dhameliya TM; Chhabria MT
J AOAC Int; 2022 Feb; 105(1):1-10. PubMed ID: 34338773
[TBL] [Abstract][Full Text] [Related]
18. Regulatory Updates and Analytical Methodologies for Nitrosamine Impurities Detection in Sartans, Ranitidine, Nizatidine, and Metformin along with Sample Preparation Techniques.
Shaik KM; Sarmah B; Wadekar GS; Kumar P
Crit Rev Anal Chem; 2022; 52(1):53-71. PubMed ID: 32691615
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous analysis of carcinogenic N-nitrosamine impurities in metformin tablets using on-line in-tube solid-phase microextraction coupled with liquid chromatography-tandem mass spectrometry.
Ishizaki A; Ozawa K; Kataoka H
J Chromatogr A; 2023 Nov; 1710():464416. PubMed ID: 37804578
[TBL] [Abstract][Full Text] [Related]
20. A highly sensitive LC-MS/MS method for the determination and quantification of a recently identified
Wang Z; Hu S; Wu X; He Z; Ke C; Hu M
Anal Methods; 2023 Jan; 15(3):256-260. PubMed ID: 36598084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
